Search
Search Results
##search.searchResults.foundPlural##
-
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3623PDF: 1371HTML: 2409Fi.1 Gritti.Rambaldi: 262 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4390PDF: 2094HTML: 1973 -
SOLITARY PLASMACYTOMA
4300PDF: 2288HTML: 1424fIGURES 1,2: 281 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2626PDF: 862HTML: 1756 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3921PDF: 1726HTML: 106 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1307PDF: 587HTML: 1719Figures: 213Fifures Sanz: 224tables Sanz: 227Untitled: 224 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2132PDF: 1986HTML: 812 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2378PDF: 791HTML: 373 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2158PDF: 965HTML: 1110 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2810PDF: 1010HTML: 604 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3693PDF: 1411HTML: 6365 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2090PDF: 879HTML: 264 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
2253PDF: 1135HTML: 329 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4221PDF: 1329HTML: 2128Table 1: 238 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
930PDF: 522HTML: 1318 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4446PDF: 1611HTML: 482 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3226PDF: 1086HTML: 3241 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4231PDF: 1184HTML: 923 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3448PDF: 979HTML: 1558Fig.1 CHL-R paper: 268Fig 2 CHL-R paper: 303 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1409PDF: 926HTML: 277 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2760PDF: 941HTML: 2141 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1433PDF: 1123HTML: 456 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1744PDF: 1144HTML: 501 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
875PDF: 587HTML: 4043 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3772PDF: 1207HTML: 23387 -
-
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1614HTML: 416PDF: 1024Suppl. Files: 522 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3033PDF: 1048HTML: 7520 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2499PDF: 920HTML: 2309New table Chinese children with APL: 212 -
ACQUIRED REFRACTORY IRON DEFICIENCY
3781PDF: 1301HTML: 1602 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2334PDF: 1712HTML: 736 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3911PDF: 1180HTML: 2505Figure 1: 248 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3917PDF: 1313HTML: 5097Incidence age-standardized rates for HL across the Mediterranean basin: 259 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2276PDF: 901HTML: 270







